The respiratory tract is exposed to infection from inhaled pathogens, including viruses,
bacteria, and fungi. So far, a comprehensive assessment that integrates common and …

Coronavirus disease 2019 (COVID-19) mRNA vaccines that have contributed to controlling
the SARS-CoV-2 pandemic induce specific serum antibodies, which correlate with …

T cells have been identified as correlates of protection in viral infections. However, the level
of vaccine-induced T cells needed and the extent to which they alone can control acute viral …

A new coronavirus infection (COVID-19) was the first time reported in December 2019 and
spread worldwide in a matter of months. 1 The world COVID-19 epidemic spread throughout …

Background Understanding cellular responses to SARS-CoV-2 immunisations is important
for informing vaccine recommendations in patients with inflammatory bowel disease (IBD) …

The continued emergence of SARS-CoV-2 variants and the threat of future Sarbecovirus
zoonoses have spurred the design of vaccines that can induce broad immunity against …

The first approved vaccines for human use against severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) are nanotechnology‐based. Although they are modular …

Venous thromboembolism (VTE) is a common, deadly disease with an increasing incidence
despite preventive efforts. Clinical observations have associated elevated antibody …

T cell-mediated protection in absence of virus neutralizing antibodies | Nature Microbiology
Skip to main content Thank you for visiting nature.com. You are using a browser version …

New vaccine formulations are based on circulating strains of virus, which have tended to
evolve to more readily transmit human to human and to evade the neutralizing antibody …